Quantcast

U.K. MIDWEEKS: HARRY HEADS IN #1 DIRECTION 

Harry Styles is #1 on the U.K’s Official Albums midweek update with his Columbia self-titled debut sitting 24k combined sales ahead of Ed Sheeran. Styles’ “Sign of the Times” has risen seven places to reach #3 on the Official Singles Chart.

He's looking to become the second 1D member to reach #1 in Blighty following ZAYN whose RCA-issued Mind of Mine topped the chart in 2016.

Styles played a well-received intimate surprise show at 600-capacity The Garage in London on Saturday, where pop critics applauded his newfound rock style and solo showmanship.

There are two other new entries in today’s Top 5. Paramore are #3 with After Laughter (Atlantic), followed by Paul Weller at #4 with A Kind Revolution (Parlophone). British rapper J Hus is also on course for the Top 10 with debut album Common Sense (Black Butter) currently at #6.

On the singles update, last week’s #1, “Despacito” (Polydor) by Luis Fonsi, Daddy Yankee and Justin Bieber, looks set to stay put for a second week—it has a 13k combined sales lead ahead of “I’m the One” (Black Butter/Def Jam) by DJ Khaled.

Alongside “Sign of the Times” at #3, all 10 of the tracks from Styles debut could chart within the Top 100. The second highest entry is “Sweet Creature” at #47. Finally, Miley Cyrus looks set for her highest U.K. charting single since “Wrecking Ball” hit #1 in 2013 as “Malibu” (RCA) enters at #7.

UMG BROADENS SPOTIFY OFFERINGS
Sir Lucian and Daniel are in harmony. (3/28a)
THE COUNT: COLDPLAY IS HOT, COUNTRY'S COOKIN' IN THE U.K.
The latest tidbits from the bustling live sector (3/28a)
YTD MARKET SHARE
Zeroing in on the elite teams (3/28a)
TRUST IN THE TOP 20
Hip-hop is no longer hibernating. (3/28a)
SONG REVENUE:
A STYLISTIC STEW
MC, divas and singer-songwriters rub elbows. (3/28a)
THE NEW UMG
Gosh, we hope there are more press releases.
TIKTOK BANNED!
Unless the Senate manages to make this whole thing go away, that is.
THE NEW HUGE COUNTRY ACT
No, not that one.
TRUMP'S CAMPAIGN PLAYLIST
Now 100% unlicensed!
 Email

 First Name

 Last Name

 Company

 Country
CAPTCHA code
Captcha: (type the characters above)